Development of a novel anti-neuroinflammatory experimental therapeutic for epilepsy and Alzheimer's risk

Project: Research project

Project Details

StatusActive
Effective start/end date12/15/2311/30/25

Funding

  • ImmunoChem Therapeutics, LLC (AWD00001254/60067854 AMD 1 // 5R44AG071062-03)
  • National Institute on Aging (AWD00001254/60067854 AMD 1 // 5R44AG071062-03)